Cargando…
Therapy of polycythemia vera: is it time to change?
Autores principales: | Passamonti, Francesco, Maffioli, Margherita, Mora, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732684/ https://www.ncbi.nlm.nih.gov/pubmed/29262518 http://dx.doi.org/10.18632/oncotarget.22282 |
Ejemplares similares
-
Is there a gender effect in polycythemia vera?
por: Palandri, Francesca, et al.
Publicado: (2020) -
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project
por: Barraco, Daniela, et al.
Publicado: (2018) -
Ruxolitinib in Myelofibrosis and Polycythemia Vera
por: Wolfe, Leah
Publicado: (2016) -
Thromboembolic events in polycythemia vera
por: Griesshammer, Martin, et al.
Publicado: (2019) -
Genetic Background of Polycythemia Vera
por: Regimbeau, Mathilde, et al.
Publicado: (2022)